Terms: = Prostate cancer AND KLK2, P20151, 3817, ENSG00000167751, MGC12201, hK2, KLK2A2 AND Treatment
82 results:
1. Observation of Serological Index and Efficacy of Abiraterone Hydrochloride Tablets Combined with Endocrine Therapy in Patients with Metastatic Castration-Resistant prostate cancer.
Yu L; Sun H; Che M; Gai W
Arch Esp Urol; 2023 Oct; 76(8):588-595. PubMed ID: 37960958
[TBL] [Abstract] [Full Text] [Related]
2. The effect of Ganoderma lucidum polysaccharide extract on sensitizing prostate cancer cells to flutamide and docetaxel: an in vitro study.
Rahimnia R; Akbari MR; Yasseri AF; Taheri D; Mirzaei A; Ghajar HA; Farashah PD; Baghdadabad LZ; Aghamir SMK
Sci Rep; 2023 Nov; 13(1):18940. PubMed ID: 37919464
[TBL] [Abstract] [Full Text] [Related]
3. Antagonism of androgen receptor signaling by aloe-emodin.
Zhao J; Sun Y; Ren L; Huang S; Zhang J
Food Chem Toxicol; 2023 Nov; 181():114092. PubMed ID: 37806336
[TBL] [Abstract] [Full Text] [Related]
4. Preclinical Development in Radiopharmaceutical Therapy for prostate cancer.
Alati S; Singh R; Pomper MG; Rowe SP; Banerjee SR
Semin Nucl Med; 2023 Sep; 53(5):663-686. PubMed ID: 37468417
[TBL] [Abstract] [Full Text] [Related]
5. Quercetin can be a more reliable treatment for metastatic prostate cancer than the localized disease: An in vitro study.
Mirzaei A; Deyhimfar R; Azodian Ghajar H; Mashhadi R; Noori M; Dialameh H; Aghsaeifard Z; Aghamir SMK
J Cell Mol Med; 2023 Jun; 27(12):1725-1734. PubMed ID: 37232542
[TBL] [Abstract] [Full Text] [Related]
6. Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of prostate cancer Radiotherapy Response.
Storey CM; Altai M; Bicak M; Veach DR; Lückerath K; Adrian G; McDevitt MR; Kalidindi T; Park JE; Herrmann K; Abou D; Zedan W; Peekhaus N; Klein RJ; Damoiseaux R; Larson SM; Lilja H; Thorek D; Ulmert D
Mol Cancer Res; 2023 Apr; 21(4):307-315. PubMed ID: 36608299
[TBL] [Abstract] [Full Text] [Related]
7. The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines.
Rezaeian A; Khatami F; Heidari Keshel S; Akbari MR; Mirzaei A; Gholami K; Mohammadi Farsani R; Aghamir SMK
Sci Rep; 2022 Dec; 12(1):20924. PubMed ID: 36463254
[TBL] [Abstract] [Full Text] [Related]
8. Computer-Aided Design of Lasso-like Self-Assembling Anticancer Peptides with Multiple Functions for Targeted Self-Delivery and cancer treatments.
Pei P; Chen L; Fan R; Zhou XR; Feng S; Liu H; Guo Q; Yin H; Zhang Q; Sun F; Peng L; Wei P; He C; Qiao R; Wang Z; Luo SZ
ACS Nano; 2022 Sep; 16(9):13783-13799. PubMed ID: 36099446
[TBL] [Abstract] [Full Text] [Related]
9. pH-sensitive nanoliposomes for passive and CXCR-4-mediated marine yessotoxin delivery for cancer therapy.
Vieira AM; Silvestre OF; Silva BF; Ferreira CJ; Lopes I; Gomes AC; Espiña B; Sárria MP
Nanomedicine (Lond); 2022 Apr; 17(10):717-739. PubMed ID: 35481356
[No Abstract] [Full Text] [Related]
10. Novel combination therapy of prostate cancer cells with arsenic trioxide and flutamide: An in-vitro study.
Mirzaei A; Akbari MR; Tamehri Zadeh SS; Khatami F; Mashhadi R; Aghamir SMK
Tissue Cell; 2022 Feb; 74():101684. PubMed ID: 34800879
[TBL] [Abstract] [Full Text] [Related]
11. Case Study of Noni Extract in Men with Very Low-Risk or Low-Risk prostate cancer.
Hirasawa Y; Pagano I; Huang J; Sasaki Y; Murakami K; Rosser CJ; Furuya H
Hawaii J Health Soc Welf; 2021 Oct; 80(10):242-250. PubMed ID: 34661119
[TBL] [Abstract] [Full Text] [Related]
12. Cyclopentenone-Containing Tetrahydroquinoline and Geldanamycin Alkaloids from
Xie Y; Guo L; Huang J; Huang X; Cong Z; Liu Q; Wang Q; Pang X; Xiang S; Zhou X; Liu Y; Wang J; Wang J
J Nat Prod; 2021 Jul; 84(7):2004-2011. PubMed ID: 34225450
[TBL] [Abstract] [Full Text] [Related]
13. Anti-androgenic effect of astaxanthin in LNCaP cells is mediated through the aryl hydrocarbon-androgen receptors cross talk.
Montazeri-Najafabady N; Chatrabnous N; Arabnezhad MR; Azarpira N
J Food Biochem; 2021 Apr; 45(4):e13702. PubMed ID: 33694182
[TBL] [Abstract] [Full Text] [Related]
14. Cabozantinib can block growth of neuroendocrine prostate cancer patient-derived xenografts by disrupting tumor vasculature.
Labrecque MP; Brown LG; Coleman IM; Nguyen HM; Lin DW; Corey E; Nelson PS; Morrissey C
PLoS One; 2021; 16(1):e0245602. PubMed ID: 33471819
[TBL] [Abstract] [Full Text] [Related]
15. Chronic IL-1 exposure drives LNCaP cells to evolve androgen and AR independence.
Dahl HC; Kanchwala M; Thomas-Jardin SE; Sandhu A; Kanumuri P; Nawas AF; Xing C; Lin C; Frigo DE; Delk NA
PLoS One; 2020; 15(12):e0242970. PubMed ID: 33326447
[TBL] [Abstract] [Full Text] [Related]
16. KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
Lunger L; Retz M; Bandur M; Souchay M; Vitzthum E; Jäger M; Weirich G; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Koll F; Gschwend JE; Nawroth R; Heck MM
Prostate Cancer Prostatic Dis; 2021 Jun; 24(2):362-369. PubMed ID: 32978525
[TBL] [Abstract] [Full Text] [Related]
17. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract] [Full Text] [Related]
18. Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.
Horie K; Kawakami K; Fujita Y; Matsuda Y; Arai T; Suzui N; Miyazaki T; Koie T; Mizutani K; Ito M
Oncology; 2020; 98(10):734-742. PubMed ID: 32726790
[TBL] [Abstract] [Full Text] [Related]
19. Genetic signature of prostate cancer mouse models resistant to optimized hk2 targeted α-particle therapy.
Bicak M; Lückerath K; Kalidindi T; Phelps ME; Strand SE; Morris MJ; Radu CG; Damoiseaux R; Peltola MT; Peekhaus N; Ho A; Veach D; Malmborg Hager AC; Larson SM; Lilja H; McDevitt MR; Klein RJ; Ulmert D
Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15172-15181. PubMed ID: 32532924
[TBL] [Abstract] [Full Text] [Related]
20. Preclinical efficacy of hk2 targeted [
Timmermand OV; Elgqvist J; Beattie KA; Örbom A; Larsson E; Eriksson SE; Thorek DLJ; Beattie BJ; Tran TA; Ulmert D; Strand SE
Theranostics; 2019; 9(8):2129-2142. PubMed ID: 31149033
[TBL] [Abstract] [Full Text] [Related]
[Next]
